Naomi Aoki | SVP, Corporate Communications & IR |
Bryan Stuart | President & CEO |
Judy Dunn | President, R&D |
Esther Rajavelu | CFO |
Chris Morabito | CMO |
Paul Bruno | Executive Director, Corporate Development |
Judah Frommer | Credit Suisse |
Dae Gon Ha | Stifel |
Ted Tenthoff | Piper Sandler |
Joseph Schwartz | SVB |
Matt Biegler | Oppenheimer |
Good morning and welcome to Fulcrum Therapeutics' First Quarter 2022 Conference Call. Currently all participants are in a listen-only mode. There will be a question-and-answer session at the end of this call. I would now like to turn the call over to Naomi Aoki, Senior Vice President of Corporate Communications and Investor Relations at Fulcrum. Please proceed.